MedTrace Logo

Public Health Emergency: SOLIDARITY TRIAL Philippines

NCT05024006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1314

Last updated 2022-03-02

No results posted yet for this study

Summary

This study is an adaptive, randomized, open-label, controlled clinical trial utilizing an adaptive design to compare effects of repurposed drugs with local standard of care alone on major inpatient hospital outcomes. This is performed worldwide in collaboration with WHO.

Conditions

  • Covid19

Interventions

DRUG

Remdesivir

Two intravenous loading doses, then daily infusion for 10 days

DRUG

Hydroxychloroquine

Two oral loading doses, then orally twice daily for 10 days

DRUG

Lopinavir / Ritonavir

Orally twice daily for 14 days

DRUG

Interferon beta-1a

Daily injection for 6 days

DRUG

Acalabrutinib

Orally twice daily for 10 days

Sponsors & Collaborators

  • University of the Philippines

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2021-04-17
Completion
2021-04-17

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05024006 on ClinicalTrials.gov